Insulet
PODD
#1416
Rank
$11.83 B
Marketcap
$169.25
Share price
3.20%
Change (1 day)
-40.08%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $1.72

According to Insulet's latest financial reports the company's current EPS (TTM) is $1.72. In 2022 the company made an earnings per share (EPS) of $0.07000 a decrease over its 2021 EPS that were of $0.23.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.722357.14%
2022$0.07000-69.57%
2021$0.23109.09%
2020$0.11-38.89%
2019$0.18200%
2018$0.06000-113.04%
2017-$0.46-9.8%
2016-$0.51-60.77%
2015-$1.3039.78%
2014-$0.9312.05%
2013-$0.83-23.15%
2012-$1.0810.2%
2011-$0.98-36.36%
2010-$1.54-36.63%
2009-$2.43-29.36%
2008-$3.44-86.74%
2007-$25.95-64.04%
2006-$72.15122.23%
2005-$32.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$14.09 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.72 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$5.43 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.23-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.02-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.98-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA